“AryoGen”的意思、由来-开放百科全书

词条

AryoGen

释义

History
Products
See also
References
External links

{{COI|date=February 2017}}{{more citations needed|date=February 2017}}{{Infobox company
|name = AryoGen
|logo = AryoGen Biopharma Logo.png
|type = Private Company
|area_served = Worldwide
|key_people = Dr. Fereidoun Mahboudi
Chairman
|industry = Pharmaceutical
|products = biopharmaceuticals, Monoclonal antibody
|revenue = {{Increase}} US$ 100 million
|operating_income =
|net_income =
|assets =
|equity =
|num_employees = {{Increase}} 300+ (2015)
|divisions =
|subsid =
|slogan =
|
|foundation = 2009
|location_city = Tehran
|location_country = Iran
|homepage = AryoGen
}}AryoGen Pharmed (in Persian: آریوژن فارمد ) is an Iranian biopharmaceutical company specializing in manufacturing Therapeutic Monoclonal antibodies and some other recombinant proteins.^[1]^[2]^[3]

History

AryoGen is a biopharmaceutical company created on the mandate of Iranian executive branch. It was created by a group of scientific experts spun off a well versed Biopharmaceutical company, which formed a totally new entity christened as AryoGen Biopharma which started its production in 2011. It was deemed an issue of national interest due to the importance of the target products on Iran's community health care system, as well as its impact in the region and around the world.

AryoGen is the world's first company to produce biosimilar Blood Coagulation Factor VII, which required a 50 million Euros product investment. Also AryoGen has established a monoclonal antibodies production line amongst only 10 manufacturer of the world.

AryoGen has changed his name to AryoGen Pharmed since 2016.

Products

AryoGen's products include:

Blood Coagulation factor VII with the name of AryoSeven which is a biosimilar form of Novoseven with multi billion dollars world market and is used for hemophilia patients and other conditions
Altebrel with the generic name of Etanercept and original trade name of Enbrel which for some years was the no. one in the biopharmaceutical market and is used for treatment of autoimmune diseases
Zytux with the generic name of Rituximab and original trade name of Rituxan which is an anticancer biomedicine,
َAryoTrust with the generic name of trastuzumab and original name of Herceptin which is a revolutionary drug in treatment of breast cancer
Stivant with the generic name of bevacizumab and original trade name of Avestin and is used for treatment of some sort of cancer.

AryoSeven is now approved by Iranian food and drug organisation and from Aug 2012 is in the market and other biomedicines are closing to the market.

{{wide image|AryoGen Biopharma Complex panorama.jpg|1100px|alt= 22000 sqm AryoGen Biopharma complex in a panorama photo|align-cap=center|AryoGen Pharmed Complex.}}

References

1. ^{{cite web |url=http://www.highbeam.com/doc/1G1-279301420.html |archive-url=https://web.archive.org/web/20141001104058/http://www.highbeam.com/doc/1G1-279301420.html |dead-url=yes |archive-date=2014-10-01 |title=IRAN, ISLAMIC REPUBLIC OF : Aryogen produces locally made medicines in Iran; helps Iran save up to $100 mln annually. |work=Mena Report}}
2. ^[https://web.archive.org/web/20141029165559/http://www.highbeam.com/doc/1G1-279167049.html World's 2nd factor VII factory opened in Iran. - Mehr News Agency (MNA) | HighBeam Research]
3. ^Iran launches domestic manufacture of anti-hemophilia drug - Trend.Az

External links

[https://web.archive.org/web/20120807101710/http://www.aryogen.com/ AryoGen - Home]
Hemophilia
[https://web.archive.org/web/20130312083335/http://www.list-of-companies.org/Iran/Keywords/pharmaceutical/ List of biopharmaceutical companies]
Launching domestic manufacture of anti-hemophilia drug
Related Clinical trials

3 : Biopharmaceutical companies|Pharmaceutical companies of Iran|Pharmaceutical companies established in 2009

随便看

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。

History

Products

See also

References

External links